PLURISTEM THERAPEU (Israel) Today

Equity ratings for PLURISTEM THERAPEU are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of August 2021 and ending today, the 26th of September 2021. Click here to learn more.
PLURISTEM THERAPEU cannot be verified against its exchange. Apparently, PLURISTEM THERAPEU is not available for investing at the moment. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

PLURISTEM THERAPEU Stock Profile

Pluristem Therapeutics Inc., together with its subsidiary, Pluristem Ltd., operates as a bio-therapeutics company in Israel. Pluristem Therapeutics Inc. was founded in 2001 and is based in Haifa, Israel. PLURISTEM THERAPEU operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 172 people.. The public information regarding PLURISTEM THERAPEU's current market price is not available at this time.
PLURISTEM THERAPEU is not yet fully synchronised with the market data
PLURISTEM THERAPEU has some characteristics of a very speculative penny stock
PLURISTEM THERAPEU has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 54 K. Net Loss for the year was (36.53 M) with profit before overhead, payroll, taxes, and interest of 48 K.
PLURISTEM THERAPEU has accumulated about 10.54 M in cash with (28.57 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.7.
Legal NamePLURISTEM THERAPEU
Chairman of the Board, CEOZalman Aberman  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of PLURISTEM THERAPEU's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
PLURISTEM THERAPEU (PSTI) is traded on Tel Aviv Stock Exchange in Israel and employs 172 people. The company currently falls under 'Large-Cap' category with current market capitalization of 30.35 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PLURISTEM THERAPEU's market, we take the total number of its shares issued and multiply it by PLURISTEM THERAPEU's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. PLURISTEM THERAPEU operates under Healthcare sector and is part of Biotechnology industry. The entity has 110.87 M outstanding shares. PLURISTEM THERAPEU has accumulated about 10.54 M in cash with (28.57 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.7.
Check PLURISTEM THERAPEU Probability Of Bankruptcy

PLURISTEM Stock Against Markets

Picking the right benchmark for PLURISTEM THERAPEU stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in PLURISTEM THERAPEU stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for PLURISTEM THERAPEU is critical whether you are bullish or bearish towards PLURISTEM THERAPEU at a given time.
PLURISTEM THERAPEU cannot be verified against its exchange. Apparently, PLURISTEM THERAPEU is not available for investing at the moment. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with PLURISTEM THERAPEU stock to make a market-neutral strategy. Peer analysis of PLURISTEM THERAPEU could also be used in its relative valuation, which is a method of valuing PLURISTEM THERAPEU by comparing valuation metrics with similar companies.

PLURISTEM THERAPEU Corporate Directors

PLURISTEM THERAPEU corporate directors refer to members of a PLURISTEM THERAPEU board of directors. The board of directors generally takes responsibility for the PLURISTEM THERAPEU's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of PLURISTEM THERAPEU's board members must vote for the resolution. The PLURISTEM THERAPEU board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Mark Germain - DirectorProfile
Nachum Rosman - Independent DirectorProfile
Issac Braun - DirectorProfile
Hava Meretzki - DirectorProfile
Check out Your Equity Center. Note that the PLURISTEM THERAPEU information on this page should be used as a complementary analysis to other PLURISTEM THERAPEU's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Probability Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Tools for PLURISTEM Stock

When running PLURISTEM THERAPEU price analysis, check to measure PLURISTEM THERAPEU's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PLURISTEM THERAPEU is operating at the current time. Most of PLURISTEM THERAPEU's value examination focuses on studying past and present price action to predict the probability of PLURISTEM THERAPEU's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move PLURISTEM THERAPEU's price. Additionally, you may evaluate how the addition of PLURISTEM THERAPEU to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go